🧬 Cathie Wood Bets Big on Gene Editing, Sells $30M in Tesla Stock
Cathie Wood’s Ark Invest is reshaping its portfolio by aggressively increasing exposure to gene-editing and next-generation technology companies, while continuing to trim positions in Tesla (TSLA) and select cloud and space stocks.
🧬 Ark Invest Loads Up on Gene-Editing Stocks
Ark Invest significantly increased its holdings in CRISPR Therapeutics (CRSP), adding approximately $8.8 billion in exposure by purchasing 155,649 shares. The biotech firm focuses on gene-based medicines using the CRISPR/Cas9 gene-editing platform.
- 🧬 CRISPR Therapeutics (CRSP): +155,649 shares
- 🧪 Pacific Biosciences (PACB): ~1.13M shares via ARKK & ARKG
- 🔬 Beam Therapeutics (BEAM) – added
- 🧫 Twist Bioscience (TWST) – added
The moves reinforce Ark’s long-term conviction in genomics, precision medicine, and disruptive biotechnology.
🚗 Autonomous Mobility & Aerospace Investments
Ark also expanded positions in autonomous mobility and advanced aerospace, signaling confidence in next-generation transportation and defense technology.
- 🚕 WeRide (WRD): ~979K shares via ARKQ
- ✈️ Archer Aviation (ACHR): ~447K shares via ARKX
- 🛩️ AeroVironment (AVAV): 19,248 shares
- ⚛️ Oklo (OKLO): ~107K shares (nuclear microreactors)
Oklo’s inclusion highlights Ark’s growing focus on energy solutions for AI, defense, and high-performance computing.
📉 Ark Cuts Tesla and Cloud Software Exposure
On the selling side, Ark continued reducing exposure to Tesla (TSLA), selling 60,715 shares worth approximately $30 million across ARKK, ARKW, and ARKQ.
- 🚗 Tesla (TSLA): ~$30M sold
- ☁️ Cloudflare (NET) – reduced
- 📊 Palantir (PLTR) – trimmed
- 📺 Roku (ROKU) – reduced
- 🛒 Shopify (SHOP) – trimmed
- 📉 Ibotta (IBTA), Ionis (IONS) – smaller disposals
The sales suggest a shift away from mature growth names toward higher-conviction, early-stage innovation.
📊 Market Takeaway
Cathie Wood’s latest moves reinforce Ark Invest’s strategy of rotating capital into disruptive innovation — particularly gene editing, AI-linked infrastructure, autonomous mobility, and energy technology — while reducing exposure to names that have already seen massive long-term gains.
💬 Investor Discussion
Is Cathie Wood right to rotate from Tesla into gene-editing and AI infrastructure stocks?
💬 Share your view | 📤 Share this update | 🔔 Follow for daily market news
⚠️ Informational purposes only. Not investment advice.
